Klara Hitchcock
Family · Willoughby, OHNPI 1871365593
Payments from drug & device makers
Across 252 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$595
- Novo Nordisk$460
- Bayer$421
- Amgen$391
- Corcept Therapeutics$382
- plus $3K from 15 others
What the payments were for
- Food & beverage$6,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $1,436 |
| AbbVie | 34 | $595 |
| Novo Nordisk | 23 | $460 |
| Bayer | 14 | $421 |
| Amgen | 12 | $391 |
| Corcept Therapeutics | 7 | $382 |
| Phathom Pharmaceuticals, Inc. | 16 | $358 |
| Lilly USA, LLC | 20 | $343 |
| Merck | 10 | $272 |
| E.r. Squibb & Sons, L.L.C. | 14 | $272 |
| Exact Sciences | 12 | $259 |
| GSK | 16 | $254 |
| Pfizer | 11 | $198 |
| Astellas Pharma US Inc | 8 | $185 |
| Sumitomo Pharma America, Inc. | 5 | $119 |
| Xeris Pharmaceuticals, Inc. | 5 | $103 |
| Antares Pharma, Inc. | 4 | $77 |
| Boehringer Ingelheim | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $61 |
| Halozyme Inc | 2 | $47 |
| Johnson & Johnson | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,340 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 61 | $44,876 |
| MounjaroTirzepatide | 45 | $43,785 |
| OzempicSemaglutide | 27 | $37,233 |
| EliquisApixaban | 32 | $24,518 |
| UbrelvyUbrogepant | 15 | $21,578 |
| TrulicityDulaglutide | 18 | $18,702 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $16,874 |
| JardianceEmpagliflozin | 14 | $11,604 |
| XareltoRivaroxaban | 11 | $7,146 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,127 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 103 | $1,834 |
| Lidocaine | 11 | $1,412 |
| Gabapentin | 81 | $949 |
| Metoprolol Succinate | 52 | $835 |
| Rosuvastatin Calcium | 63 | $825 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $343 | $62,48763 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,436 | $61,75180 claims |
| Novo NordiskOzempic | $460 | $37,23327 claims |
| PfizerEliquis | $198 | $24,51832 claims |
| AbbVieUbrelvy | $595 | $21,57815 claims |
| Boehringer IngelheimJardiance | $69 | $11,60414 claims |
| Johnson & JohnsonXarelto | $39 | $7,14611 claims |
| GSKTrelegy Ellipta | $254 | $7,12711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Willoughby
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.